A buyout at this point in time would be extremely bad for XXII investors IMO. Once we mature a product line it becomes a great deal more valuable and we should be able to make quite a splash in each of our product streams within a matter of a couple years. We say that we possess "disruptive" technology that should allow our IP to be a major factor in the world tobacco market, but would big tobacco pay for such IP now since we haven't yet even begun production or seen any results as to how well the world market receives our new process tobacco? What is "disruptive" technology worth and that can only be answered in what percentage of the world market it can command and we won't have any idea regarding that for at least a couple of years. Too many investors would soil their pants for $20-30 per share, but to me that is peanuts compared to holding the product long term. My regret is that the long term value of the company is far beyond the mindless "pay me today" attitude seen in far too many investors. I am talking about those investing in XXII and they don't even know the science behind our patents.
Even if we get a nice buyout package and a lot of it is in shares of the buying company, our ownership will be so diluted after becoming a part of any company with multi-millions of shares pretty much means the future stock growth will be minimal to minor. Staying a separate company as long as possible should lead IMO to fantastic revenue and profit streams which in turn lead to awesome dividends.
Many will disagree with this view, but it shows the range of thoughts on this board from those willing to bail today because the stock has lost some luster in the last week compared to those whose only bitch about the last week to ten days was that they didn't have enough dry powder to really take advantage of this incredible opportunity to add at such attractive prices.